Stockscreener 앱 받기
63.46
0.45%
-0.29
전일 마감가:
$63.75
열려 있는:
$62.85
하루 거래량:
712
Relative Volume:
0.05
시가총액:
$200.25M
수익:
$44.08M
순이익/손실:
$15.26M
주가수익비율:
14.86
EPS:
4.27
순현금흐름:
$16.91M
1주 성능:
-2.65%
1개월 성능:
-0.42%
6개월 성능:
+1.85%
1년 성능:
+9.98%
1일 변동 폭
$62.85
$62.85
1주일 범위
$62.29
$65.33
52주 변동 폭
$51.26
$68.71
Utah Medical Products Inc Stock (UTMD) Company Profile
명칭
Utah Medical Products Inc
전화
(801) 521-5301
주소
7043 S 300 WEST, MIDVALE, UT
Compare UTMD vs ISRG, BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
UTMD
Utah Medical Products Inc
|
62.85 | 203.12M | 44.08M | 15.26M | 16.91M | 4.27 |
|
ISRG
Intuitive Surgical Inc
|
485.03 | 175.03B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
162.27 | 46.42B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
79.31 | 39.37B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
235.81 | 34.98B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
41.37 | 34.41B | 28.43B | 1.16B | 1.26B | 1.4457 |
Utah Medical Products Inc 주식(UTMD)의 최신 뉴스
Mountain Lake Lodge Announces New Executive Leadership and Key Team Promotions - Weekly Voice
Global Minimally Invasive Surgical Devices Market to Witness Upsurge in Growth at a CAGR of ~7% by 2034 | DelveInsight - PR Newswire UK
(UTMD) Risk Channels and Responsive Allocation - Stock Traders Daily
Quarterly Earnings: Can Utah Medical Products Inc stock outperform in a bear marketSwing Trade & Daily Profit Maximizing Tips - baoquankhu1.vn
Can Utah Medical Products Inc sustain its profitabilityQuarterly Earnings Summary & AI Forecast for Swing Trade Picks - baoquankhu1.vn
Biomedical Gas Analyzers Market Size to Reach 3,500 USD Million by 2035, Growing at 5.4% CAGR - industrytoday.co.uk
Aug Movers: Can Utah Medical Products Inc outperform under higher oil prices2025 Market Overview & Daily Volume Surge Signals - baoquankhu1.vn
Analysis Recap: Is Utah Medical Products Inc stock undervalued right now2025 Bull vs Bear & Weekly High Potential Alerts - baoquankhu1.vn
UTMD SEC FilingsUtah Med Prods 10-K, 10-Q, 8-K Forms - Stock Titan
Utah Medical Products (STU:UTM) 5-Year Dividend Growth Rate : 2.60% (As of Sep. 2025) - GuruFocus
Earnings Recap: Why is Utah Medical Products Inc stock going down2025 Momentum Check & Free Safe Capital Growth Stock Tips - baoquankhu1.vn
Utah Medical Products (STU:UTM) Altman Z-Score : 40.23 (As of Feb. 28, 2026) - GuruFocus
UTMD Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
(UTMD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Electrosurgical Devices Market to Reach USD 10,220.04 Million by 2034, Growing at 6.34% CAGR | DelveInsight - openPR.com
Retail Trends: Is now the right time to enter RZLV2025 Fundamental Recap & Reliable Entry Point Trade Alerts - baoquankhu1.vn
Utah Medical Products Inc (STU:UTM) Valuation: Modestly Overvalued - GuruFocus
Utah Medical Products (STU:UTM) Other Stockholders Equity : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Treasury Stock : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Retained Earnings : €109.02 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products Inc (STU:UTM) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Utah Medical Products (STU:UTM) Capital Expenditure : €-0.25 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Cash, Cash Equivalents, Mar - GuruFocus
Utah Medical Products (STU:UTM) Shareholder Yield % : 8.45% (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Median PS Value - GuruFocus
Utah Medical Products (STU:UTM) FCF Yield % : 6.53 (As of Feb. 25, 2026) - GuruFocus
Utah Medical Products (STU:UTM) Debt-to-Equity : 0.00 (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Inventories, Other : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Long-Term Capital Lease Obl - GuruFocus
Utah Medical Products (STU:UTM) Minority Interest : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Operating Income : €10.00 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) 10-Year ROIIC % : 2.08% (As of Dec. 2024) - GuruFocus
Utah Medical Products (STU:UTM) YoY Rev. per Sh. Growth : 0.50% (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Accounts Payable & Accrued Expense : €2.57 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Goodwill : €11.97 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Machinery, Furniture, Equipment : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) ROIC % : 23.16% (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Short-Term Debt : €0.00 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) 3-Year ROIIC % : 22.67% (As of Dec. 2024) - GuruFocus
Utah Medical Products (STU:UTM) Sale Of Property, Plant, Eq - GuruFocus
Utah Medical Products (STU:UTM) EPS (Basic) : €3.05 (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Interest Coverage : N/A (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) EV-to-OCF : 8.64 (As of Feb. 23, 2026) - GuruFocus
Utah Medical Products (STU:UTM) Common Stock : €0.03 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Net Income From Continuing Operations : €10.35 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products Inc (STU:UTM) Competitors 2026 - GuruFocus
Utah Medical Products (STU:UTM) EBIT : €10.00 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Payments to Suppliers for G - GuruFocus
Utah Medical Products (STU:UTM) Non Operating Income : €1.51 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Total Operating Expense : €9.25 Mil (TTM As of Sep. 2025) - GuruFocus
Utah Medical Products (STU:UTM) Other Current Assets : €0.36 Mil (As of Sep. 2025) - GuruFocus
Utah Medical Products Inc (UTMD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.67%
0.14%
자본화:
|
볼륨(24시간):